MD Conference Express ADA 2012 - (Page 2)
Take our survey and get access to a free eBook!
Dear Members and Friends, We are pleased to share with you highlights from the American Diabetes Association’s 72nd Scientific Sessions, held in Philadelphia, Pennsylvania, USA, June 8-12, 2012. The articles selected for this issue of MD Conference Express® were chosen from the hundreds of presentations at the conference and represent a selection of the most newsworthy topics of relevance to a broad range of practitioners. This year’s meeting showcased a wide variety of important clinical trials, including the results of the ORIGIN Trial. The objective of the ORIGIN Trial was to assess the effects of treatment with insulin glargine versus standard care on cardiovascular outcomes. Other clinical trial highlights in this issue include closed-loop insulin therapy for nocturnal glycemic control in children, the precocious aging effect of type 1 diabetes in children, costimulation modulation with abatacept in patients with recent-onset type 1 diabetes, and the legacy effect in the United Kingdom Prospective Diabetes Study. In addition to the results of the top late-breaking clinical trials that are highlighted in this report, you will also find in-depth depth information on selected topics, including incretin-based therapies, insulin therapy, insulin analogs, diabetes, dyslipidemia, and cardiovascular disease. Our feature article looks at new lessons in hypertension and diabetes in anticipation of the new JNC 8 guidelines. We hope that you will find the articles and practical perspectives contained in the pages of this issue of MD Conference Express helpful in integrating this new information into your clinical practice, and we encourage you to plan to attend the 73rd Scientific Sessions in Chicago, Illinois, USA, June 21-25, 2013. For more information please visit: http://scientificsessions.diabetes.org. John Anderson, MD
ADA President-Elect, Medicine and Science Frist Clinic, USA
Mary-Elizabeth Patti, MD
Chair, ADA Scientific Sessions Meeting Planning Committee Investigator and Adult Endocrinologist, Joslin Diabetes Center, USA Assistant Professor of Medicine, Harvard Medical School, USA
Geralyn R. Spollett, MSN, ANP-BC, CDE
ADA President, Health Care and Education Yale University School of Medicine, USA
2
August 2012
www.mdconferencexpress.com
http://www.mdconferencexpress.com
http://www.surveymonkey.com/s/mdce_ada2012
http://scientificsessions.diabetes.org
http://www.mdconferencexpress.com
Table of Contents for the Digital Edition of MD Conference Express ADA 2012
MD Conference Express ADA 2012
Contents
ORIGIN Trial Results
New Lessons in Hypertension and Diabetes
Closed-Loop Insulin Therapy in Young Children
The Precocious “AGE’ing” Effect of Type 1 Diabetes in Children
Abatacept in Patients with New-Onset Type 1 Diabetes: One-Year Follow-Up
Explaining the UKPDS Legacy Effect
Insulin and Cancer
Insulin Analogs
Dyslipidemia
Insulin Therapy
Incretin Therapies
Diabetes and Chronic Kidney Disease Guidelines Update
Managing Hyperglycemia in Hospitalized Patients
CVD Prevention and Treatment in Women With Diabetes
China Da Qing Study: Lifestyle Change in Women With IGT Extends Life
Markers of Macrovascular Complications in Pediatric Diabetes
Nonoperative Management of the Infected Diabetic Foot
Diabetic Retinopathy: Changing Prevalence and Severity Require Flexible Interventions
New ADA/EASD Position Statement Endorses a Patient-Centered Approach
MD Conference Express ADA 2012
https://www.nxtbook.com/nxtbooks/md_conference_express/ada2012
https://www.nxtbookmedia.com